Razumab, a biosimilar of Genentech’s Lucentis, was launched in June at about 25 per cent cheaper than the innovator drug marketed by Novart...

"There are variations in each individual in conversions of codeine to morphine and each individual reacts differently," Prof K C Singhal.

Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last ye...

Assocham has said it expects the Indian pharmaceutical industry to reach $20 billion by 2015, making it one of the world's top 10 pharmaceu...